Action by Congress could be seen as thunder and flurry.
A strange thing happened recently. A bipartisan letter was sent from a group of U.S. House representatives. In the letter sent to Health and Human Services (HHS) Secretary Xavier Becerra, 181 representatives asked that HHS conclude its review of the drug companies refusing to give 340B discounts to providers using contracted pharmacy services.
Legally, the Office of Inspector General (OIG) for HHS could impose penalties of up to $6,000 per claim for knowingly overcharging providers.
It would seem that the wind is at the back of providers in the 340B battle, after the Supreme Court ruled in favor of providers on the June 15 on the cuts the Centers for Medicare & Medicaid Services (CMS) made to Medicare payments for certain drugs. While legally this seems to make sense, I want to point out the differences in the issues in the June 15 ruling and the current dispute. In the June 15 ruling, the issue were Medicare payment rates and how those rates were determined.
In the current case, HHS has the hurdle of arguing that drug providers “knowingly and intentionally” overcharged providers when, from their perspective, they are following the regulations as they interpret them. HHS, in referring the drug companies to the OIG, would have to prove that they know their position is without merit and they are simply doing it anyway.
Short of finding a whistleblower in the drug company ranks this seems impossible. Not only would you have to find one whistleblower, HHS in making a referral to the OIG would have to prove that all seven companies in identified in its letter had colluded in coming to the same conclusions.
I also think it is safe to say in the current environment trying to guess what the Supreme Court will do on any issue is extremely difficult.
In recent weeks, the Centers for Medicare & Medicaid Services (CMS) has been incredibly active in releasing a slew of updates that aim to extend
EDITOR’S NOTE: The following op-ed is exclusively comprised of the opinions of the individual author, which are not necessarily shared by RACmonitor or Monitor Mondays.
Please log in to your account to comment on this article.
The CMS Two-Midnight Rule and short-stay audits are here to stay, impacting inpatient and outpatient admissions, ASC procedures, and Medicare Parts C & D. New for 2024, the Two-Midnight Rule applies to Medicare Advantage patients, requiring differentiation between Medicare plans affecting Case Managers, Utilization Review, and operational processes and knowledge of a vital distinction between these patients that influences post-discharge medical reviews and compliance risk. Join Michael G. Calahan for a comprehensive webcast covering federal laws for all admission processes. Gain the knowledge needed to navigate audits effectively and optimize patient access points, personnel, and compliance strategies. Learn Two-Midnight Rule essentials, Medicare Advantage implications, and compliance best practices. Discover operational insights for short-stay admissions, outpatient observation, and the ever-changing Inpatient-Only Listing.
A massive task lies ahead! Now’s the time to start preparing your case management and utilization review teams for successful implementation of changes contained in the 2024 IPPS, OPPS and MPFS rules.
Gain clarity on billing, patient notifications, and discharge appeal rights in social admissions. Join our webcast for essential insights and strategies to navigate this complex landscape, ensuring financial stability and optimal patient care.
Dr. Ronald Hirsch provides tried-and-true strategies and insight into outpatient in hospital bed stays including determining the applicable definition, who uses it, and when and how to bill for this circumstance, solidified with concrete case examples and expert insight.
Explore comprehensive guidelines and best practices for secondary diagnosis coding in our illuminating webcast. Delve into the intricacies of accurately assigning secondary diagnosis codes to ensure precise medical documentation. Learn how to navigate complex scenarios and adhere to coding regulations while enhancing coding proficiency. Our expert-led webcast covers essential insights, including documentation requirements, sequencing strategies, and industry updates. Elevate your coding skills and stay current with the latest coding advancements so you can determine the correct DRG assignment to optimize reimbursement, support medical decision-making, and maintain compliance.
Enhance your inpatient coding precision and revenue with Principal Diagnosis Coding: Mastering Selection and Sequencing. Join our expert-led webcast to conquer the challenges of principal diagnosis selection and sequencing. We’ll decode the intricacies of ICD-10-CM guidelines, equipping you with a clear grasp of the rules and the official UHDDS principal diagnosis definition. Uncover the crucial role of coding conventions, master the sequencing of related conditions, and confidently tackle cases with equally valid principal diagnoses.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY24 Inpatient Prospective Payment System (IPPS) Final Rule, including new ICD-10-CM/PCS codes, plus insights, analysis and answers to questions from the country’s most respected subject matter experts.
This third session in our 2024 IPPS Summit will feature a review of FY24 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by senior healthcare consultant Laurie Johnson, with bonus insights and analysis from two acclaimed subject matter experts
Copyright © 2023 RACmonitor. Powered by MedLearn Media.
